The DEA Declines to Reschedule Marijuana. What Does This Mean for the Florida Marijuana Industry?
Posted on August 22, 2016 by Jeffrey FeilerThis past Thursday, as was predictable in my opinion, the Drug Enforcement Agency (DEA) declined to re-schedule Marijuana and maintains it is a Schedule 1 drug. Schedule 1 drugs are considered the most dangerous, addictive and have no medicinal value.
Frankly, I think this decision actually benefits those in the industry today, as Big Pharma will not be putting products into Walgreens and CVS anytime soon.
The good news however is that the DEA is allowing for research to be expanded beyond the University of Mississippi, which is the only facility in the United States presently permitted to grow and research cannabis. The DEA set forth some guidelines for those who may be able to participate in research, but they have not yet licensed any other facility to commence research operations.
Despite the DEA's position, the trend of marijuana decriminalization and legalization at the State level continues, with medical marijuana legal in 23 States and recreational in four of those States. Eleven more States, including Florida, have marijuana initiatives on the ballot in November of this year.
To learn more about Florida Medical Marijuana, contact the Feiler Marijuana Law at (305) 662-5663.
Source: Cannabis Business Times